LAURUSLABS vs RPGLIFE: Stock Comparison

Laurus Labs Limited vs RPG Life Sciences Limited

Live data: 22 July 2026, 3:03 PM IST • Source: NSE and company filings

Laurus Labs Limited is the larger company by market capitalisation. RPG Life Sciences Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Laurus Labs Limited and RPG Life Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, LAURUSLABS is more favourable on 2 of 13 scored metrics and RPGLIFE on 11These counts are context-free and are not an overall rating.

Key Differences

Market Cap
LAURUSLABS is the larger company
₹85,251 Cr vs ₹4,948 Cr
P/E Ratio
RPGLIFE has a lower P/E
43.37x vs 96.78x
P/B Ratio
RPGLIFE has a lower P/B
8.25x vs 16.22x
EPS
RPGLIFE has higher earnings per share
₹69.65 vs ₹16.46
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0.19%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs 5.3%
EPS Growth (TTM YoY)
LAURUSLABS has faster EPS growth
19.4% vs -74.5%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
23.6% vs 5.31%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLAURUSLABSRPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLAURUSLABSRPGLIFE
Live Price₹1,578.6₹3,001
Day Change-0.92%0.1%
Volume10.25 L30,180
52-Week High₹1,600.1₹3,082
52-Week Low₹810.05₹1,733
Distance from 52W High-1.34%-2.63%

Valuation

MetricLAURUSLABSRPGLIFE
Market Cap₹85,251 Cr₹4,948 Cr
P/E Ratio96.78x43.37x
P/B Ratio16.22x8.25x
EPS₹16.46₹69.65
Book Value₹98.16₹366.04
Dividend Yield0.19%0.75%

Growth

MetricLAURUSLABSRPGLIFE
Revenue Growth (TTM YoY)5.3%23.6%
EPS Growth (TTM YoY)19.4%-74.5%
Qtr Sales Growth5.31%23.6%
Qtr Profit Growth19.5%33.7%

Profitability & Leverage

MetricLAURUSLABSRPGLIFE
ROE18.3%19.3%
ROCE17.8%25.7%
Net Margin13.76%29.25%
Operating Margin26.2%20.9%
Debt to Equity0.48x0.03x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricLAURUSLABSRPGLIFE
Promoter Holding27.49%72.95%
FII Holding25.82% 0.7 pp0.87% 0.13 pp
DII Holding13.97% 1.54 pp7.45% 0.41 pp
Public Holding32.71% 0.85 pp18.73% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Laurus Labs Limited and RPG Life Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.